RAIMONDI, MICHELA
RAIMONDI, MICHELA
Dipartimento di Scienze Farmacologiche e Biomolecolari
Anticancer properties of tocotrienols : a review of cellular mechanisms and molecular targets
2019 M. Montagnani Marelli, M. Marzagalli, F. Fontana, M. Raimondi, R.M. Moretti, P. Limonta
Ca2+ overload- and ROS-associated mitochondrial dysfunction contributes to δ-tocotrienol-mediated paraptosis in melanoma cells
2021 M. Raimondi, F. Fontana, M. Marzagalli, M. Audano, G. Beretta, P. Procacci, P. Sartori, N. Mitro, P. Limonta
Cancer Stem Cells—Key Players in Tumor Relapse
2021 M. Marzagalli, F. Fontana, M. Raimondi, P. Limonta
Cellular and molecular biology of cancer stem cells in melanoma : possible therapeutic implications
2019 M. Marzagalli, M. Raimondi, F. Fontana, M. Montagnani Marelli, R.M. Moretti, P. Limonta
Epithelial-To-Mesenchymal Transition Markers and CD44 Isoforms Are Differently Expressed in 2D and 3D Cell Cultures of Prostate Cancer Cells
2019 F. Fontana, M. Raimondi, M. Marzagalli, M. Sommariva, P. Limonta, N. Gagliano
Epithelial-to-mesenchymal transition markers are differently expressed in 2D and 3D cell cultures of prostate cancer cells
2018 F. Fontana, M. Raimondi, M. Marzagalli, F. Bianchi, M. Sommariva, P. Limonta, N. Gagliano
Gonadotropin-releasing hormone receptors in prostate cancer : molecular aspects and biological functions
2020 F. Fontana, M. Marzagalli, M.M. Marelli, M. Raimondi, R.M. Moretti, P. Limonta
Mitochondria as metabolic markers of melanoma stem cells and targets of delta-tocotrienol
2019 M. Raimondi, F. Fontana, M. Marzagalli, P. Limonta
Mitochondrial functional and structural impairment is involved in the antitumor activity of δ-tocotrienol in prostate cancer cells
2020 F. Fontana, M. Raimondi, M. Marzagalli, M. Audano, G. Beretta, P. Procacci, P. Sartori, N. Mitro, P. Limonta
Natural Compounds in Prostate Cancer Prevention and Treatment: Mechanisms of Action and Molecular Targets
2020 F. Fontana, M. Raimondi, M. Marzagalli, A. Di Domizio, P. Limonta
Role of Endoplasmic Reticulum Stress in the Anticancer Activity of Natural Compounds
2019 P. Limonta, R.M. Moretti, M. Marzagalli, F. Fontana, M. Raimondi, M. Montagnani Marelli
The emerging role of paraptosis in tumor cell biology: Perspectives for cancer prevention and therapy with natural compounds
2020 F. Fontana, M. Raimondi, M. Marzagalli, A. Di Domizio, P. Limonta
THE KEY ROLE OF MITOCHONDRIA IN HUMAN MELANOMA CELLS: A TARGET OF DELTA-TOCOTRIENOL ANTI-CANCER ACTIVITY AND A STEMNESS MARKER
2021 M. Raimondi
Three-Dimensional Cell Cultures as an In Vitro Tool for Prostate Cancer Modeling and Drug Discovery
2020 F. Fontana, M. Raimondi, M. Marzagalli, M. Sommariva, N. Gagliano, P. Limonta
Tocotrienols and Cancer: From the State of the Art to Promising Novel Patents
2019 F. Fontana, M. Raimondi, M. Marzagalli, R.M. Moretti, M.M. Marelli, P. Limonta
Unraveling the molecular mechanisms and the potential chemopreventive/therapeutic properties of natural compounds in melanoma
2019 F. Fontana, M. Raimondi, A. Di Domizio, R.M. Moretti, M. Montagnani Marelli, P. Limonta
δ‐Tocotrienol induces apoptosis, involving endoplasmic reticulum stress and autophagy, and paraptosis in prostate cancer cells
2019 F. Fontana, R.M. Moretti, M. Raimondi, M. Marzagalli, G. Beretta, P. Procacci, P. Sartori, M. Montagnani Marelli, P. Limonta
δ‐Tocotrienol sensitizes and re‐sensitizes ovarian cancer cells to cisplatin via induction of G1 phase cell cycle arrest and ROS/MAPK‐mediated apoptosis
2021 F. Fontana, M. Marzagalli, M. Raimondi, V. Zuco, N. Zaffaroni, P. Limonta